Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,397 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Temporal modulation (early escalation and late de-escalation) of antiplatelet therapy in patients undergoing complex high-risk PCI: rationale and design of the TAILORED-CHIP trial.
Park H, Kang DY, Ahn JM, Yun SC, Park KH, Kang SH, Suh J, Bae JW, Park S, Cho JH, Suh JW, Lee BK, Rha SW, Won H, Jang JS, Kim MH, Lee CH, Ahn YK, Oh JH, Bae JS, Park CS, Choi J, Lee JB, Lee SW, Hur SH, Kwon O, Park SJ, Park DW, Tailored-Chip Trial Investigators OBOT. Park H, et al. Among authors: lee ch, lee sw, lee bk, lee jb. EuroIntervention. 2024 Nov 4;20(21):e1355-e1362. doi: 10.4244/EIJ-D-24-00437. EuroIntervention. 2024. PMID: 39492701 Free article. Clinical Trial.
Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation.
Lee BK, Lee SW, Park SW, Lee SW, Park DW, Kim YH, Lee CW, Hong MK, Kim JJ, Jang S, Chi HS, Park SJ. Lee BK, et al. Among authors: lee sw, lee cw. Am J Cardiol. 2007 Aug 15;100(4):610-4. doi: 10.1016/j.amjcard.2007.03.070. Epub 2007 Jun 29. Am J Cardiol. 2007. PMID: 17697815 Clinical Trial.
A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.
Lee SW, Park SW, Kim YH, Yun SC, Park DW, Lee CW, Kang SJ, Park SJ, Lee JH, Choi SW, Seong IW, Lee NH, Cho YH, Shin WY, Lee SJ, Lee SW, Hyon MS, Bang DW, Choi YJ, Kim HS, Lee BK, Lee K, Park HK, Park CB, Lee SG, Kim MK, Park KH, Park WJ; DECLARE-LONG II Study Investigators. Lee SW, et al. Among authors: lee cw, lee sg, lee sj, lee bk, lee k, lee nh, lee jh. J Am Coll Cardiol. 2011 Mar 15;57(11):1264-70. doi: 10.1016/j.jacc.2010.10.035. J Am Coll Cardiol. 2011. PMID: 21392640 Free article. Clinical Trial.
Preventive strategies of renal insufficiency in patients with diabetes undergoing intervention or arteriography (the PREVENT Trial).
Lee SW, Kim WJ, Kim YH, Park SW, Park DW, Yun SC, Lee JY, Kang SJ, Lee CW, Lee JH, Choi SW, Seong IW, Suh J, Cho YH, Lee NH, Cheong SS, Yoo SY, Lee BK, Lee SG, Hyon MS, Shin WY, Lee SW, Jang JS, Park SJ. Lee SW, et al. Among authors: lee cw, lee sg, lee bk, lee nh, lee jy, lee jh. Am J Cardiol. 2011 May 15;107(10):1447-52. doi: 10.1016/j.amjcard.2011.01.019. Epub 2011 Mar 17. Am J Cardiol. 2011. PMID: 21420063 Clinical Trial.
Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial.
Kim WJ, Lee SW, Park SW, Kim YH, Yun SC, Lee JY, Park DW, Kang SJ, Lee CW, Lee JH, Choi SW, Seong IW, Lee BK, Lee NH, Cho YH, Shin WY, Lee SJ, Lee SW, Hyon MS, Bang DW, Park WJ, Kim HS, Chae JK, Lee K, Park HK, Park CB, Lee SG, Kim MK, Park KH, Choi YJ, Cheong SS, Yang TH, Jang JS, Her SH, Park SJ; ESSENCE-DIABETES Study Investigators. Kim WJ, et al. Among authors: lee sw, lee cw, lee sg, lee sj, lee bk, lee k, lee nh, lee jy, lee jh. Circulation. 2011 Aug 23;124(8):886-92. doi: 10.1161/CIRCULATIONAHA.110.015453. Epub 2011 Aug 1. Circulation. 2011. PMID: 21810659 Clinical Trial.
Comparison of Zotarolimus-Eluting stent versus Sirolimus-Eluting stent for de novo coronary artery disease in patients with diabetes mellitus from the ESSENCE-DIABETES II trial.
Park GM, Lee SW, Park SW, Kim YH, Yun SC, Cho YR, Ahn JM, Lee JY, Kim WJ, Park DW, Kang SJ, Lee CW, Lee BK, Lee NH, Cho YH, Suh J, Shin WY, Lee SJ, Lee SW, Park WJ, Kim HS, Lee SG, Cheong SS, Her SH, Park MW, Kim CJ, Park SJ. Park GM, et al. Among authors: lee sw, lee cw, lee sg, lee sj, lee bk, lee nh, lee jy. Am J Cardiol. 2013 Nov 15;112(10):1565-70. doi: 10.1016/j.amjcard.2013.07.012. Epub 2013 Sep 21. Am J Cardiol. 2013. PMID: 24063840 Clinical Trial.
Additional postdilatation using noncompliant balloons after everolimus-eluting stent implantation: Results of the PRESS trial.
Park GM, Lee JH, Choi SW, Jeong JO, Shin ES, Bae JW, Yoon HJ, Jung KT, Baek JY, Choi WG, Choi RK, Her SH, Lee JB, Suh J, Lee JB, Lee SW, Chae IH, Choi SY, Seong IW. Park GM, et al. Among authors: lee sw, lee jb, lee jh. Clin Cardiol. 2020 Jun;43(6):606-613. doi: 10.1002/clc.23355. Epub 2020 Mar 16. Clin Cardiol. 2020. PMID: 32176364 Free PMC article. Clinical Trial.
Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients With Coronary Stents Undergoing Low-to-Intermediate Risk Noncardiac Surgery.
Kang DY, Lee SH, Lee SW, Lee CH, Kim C, Jang JY, Mehta N, Oh JH, Cho YR, Yoon KH, Ahn SG, Lee JH, Cho DK, Kim Y, Kim J, Cho GH, Lee KS, Park H, Vural M, Lim YH, Park KH, Lee BK, Lee JY, Park HW, Yoon YH, Lee JH, Lee SY, Park KW, Kang J, Kim HK, Kang SH, Park JH, Choi IC, Yu CS, Yun SC, Park DW, Hong MK, Park SJ, Kim JS, Ahn JM; ASSURE DES Investigators. Kang DY, et al. Among authors: lee sh, lee ch, lee sw, lee sy, lee bk, lee ks, lee jy, lee jh. J Am Coll Cardiol. 2024 Dec 10;84(24):2380-2389. doi: 10.1016/j.jacc.2024.08.024. Epub 2024 Aug 31. J Am Coll Cardiol. 2024. PMID: 39217573 Free article. Clinical Trial.
Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
Hong MK, Lee CW, Kim YH, Park DW, Lee SW, Park CB, Jang JS, Han KH, Cheong SS, Kim JJ, Park SW, Park SJ. Hong MK, et al. Among authors: lee cw, lee sw. Am J Cardiol. 2006 Oct 1;98(7):866-70. doi: 10.1016/j.amjcard.2006.04.025. Epub 2006 Aug 4. Am J Cardiol. 2006. PMID: 16996864
8,397 results